remy biosciences
Brent Cahill is currently a Member of the Board of Advisors at Datarocx Inc. and Executive Vice President at remy biosciences. While at Remy Biosciences, Brent authored three critical patents that significantly improved active ingredient delivery. As a Senior Program Manager at an undisclosed company, Brent oversaw the research, development, manufacture, and sales of multiple pharmaceutical delivery devices. Prior to their current roles, Brent worked as a Research Analyst at Lifetech Global and as an Intern at MacGillivray Freeman Films. Brent holds a Bachelor's Degree in Computer Science from Caltech.
This person is not in any teams
remy biosciences
Remy Biosciences believes there is a better way to deliver active ingredients into the body, and by doing so achieving better wellness for all. We've spent years proving what can be done, and building the mechanisms with which to do so. Remy focuses on foundational intellectual property for delivery of molecules and compounds transdermally, through the dermal (skin) layer, as well as orally, through sublingual tablets that deliver molecules through mucosal pathways (under the tongue). The portfolio summarized below is inclusive of formally issued and pending patents worldwide.